poisar

Stocks · News reference

Scotiabank Maintains Sector Outperform on Corpay, Raises Price Target to $539

BenzingaBenzinga Newsdesk

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Zacks Investment ResearchNa

    Corpay Stock Rises 13.3% in 3 Months: Here's What You Should Know

    Corpay (CPAY) shares gained 13.3% over three months, outperforming the industry's 8.8% growth. The company delivered 18% organic revenue growth in Q3 driven by 24% increase in organic spending to $95B. Strategic acquisitions (Alpha and Avid) are delivering better-than-expected returns with combined EPS accretion exceeding $1.40 in 2026. With strong free cash flow generation and planned $2B deployment toward acquisitions or buybacks in 2027, management expects mid-teen growth or better in 2027.